Insider Trading & Ownership - Sio Gene Therapies Inc. (SIOX)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sio Gene Therapies Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-23
Purchase
2021-03-24
7:21 pm
Sio Gene Therapies Inc.SIOXCheruvu Pavan
Chief Executive Officer
100,000$2.4818$248,180180,426
(Direct)
View
2020-11-24
Purchase
2020-11-25
9:07 pm
Sio Gene Therapies Inc.SIOXPande Atul
Director
10,000$2.3399$23,39933,370
(Indirect)
View
2020-07-08
Purchase
2020-07-10
6:12 pm
Axovant Gene Therapies Ltd.AXGTPande Atul
Director
10,000$2.729$27,29023,370
(Indirect)
View
2020-07-08
Purchase
2020-07-10
6:11 pm
Axovant Gene Therapies Ltd.AXGTCheruvu Pavan
Principal Executive Officer
37,500$2.737$102,63857,836
(Direct)
View
2020-03-16
Purchase
2020-03-18
8:20 pm
Axovant Gene Therapies Ltd.AXGTPande Atul
Director
10,000$1.7844$17,84413,370
(Indirect)
View
2020-02-24
Purchase
2020-02-27
7:49 pm
Axovant Gene Therapies Ltd.AXGTRoivant Sciences Ltd.
10% Owner
5,333,333$3.75$19,999,99918,577,380
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-02-08
Option Award
2022-02-10
5:07 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXMeswani Parag V
Chief Commercial Officer
153,700$0153,700
(Direct)
View
2022-02-08
Option Award
2022-02-10
5:05 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Interim CEO, CFO
546,500$0546,500
(Direct)
View

Ownership
2022-02-07
7:17 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXMeswani Parag V
Chief Commercial Officer
0$0368,799
(Direct)
View
2021-12-08
Option Award
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
17,534$080,310
(Direct)
View
2021-12-08
Disposition
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
17,534$080,310
(Direct)
View
2021-12-08
Tax Withholding
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
6,294$1.4280,310
(Direct)
View
2021-12-08
Option Award
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXCheruvu Pavan
Chief Executive Officer
37,567$0278,242
(Direct)
View
2021-12-08
Disposition
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXCheruvu Pavan
Chief Executive Officer
37,567$0278,242
(Direct)
View
2021-12-08
Tax Withholding
2021-12-09
6:31 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXCheruvu Pavan
Chief Executive Officer
14,884$1.42278,242
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:59 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXVuori Kristiina MD
Director
42,000$042,000
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:57 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXTorti Frank
Director
42,000$042,000
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:56 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXSundaram Senthil Vel
Director
42,000$042,000
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:55 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXPande Atul
Director
42,000$042,000
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:54 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXModig Berndt
Director
42,000$042,000
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:53 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
239,000$0239,000
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:52 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXCorcoran Gavin
Chief R&D Officer
244,300$0244,300
(Direct)
View
2021-04-15
Option Award
2021-04-19
4:51 pm
N/A
2031-04-14
Sio Gene Therapies Inc.SIOXCheruvu Pavan
Chief Executive Officer
682,100$0682,100
(Direct)
View
2021-03-22
Option Award
2021-03-22
9:25 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
15,060$034,004
(Direct)
View
2021-03-22
Disposition
2021-03-22
9:25 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXNassif David W.
Chief Financial Officer
15,060$034,004
(Direct)
View
2021-03-17
Option Award
2021-03-19
4:58 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXCorcoran Gavin
Chief R&D Officer
16,001$025,792
(Direct)
View
2021-03-17
Disposition
2021-03-19
4:58 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXCorcoran Gavin
Chief R&D Officer
16,001$025,792
(Direct)
View
2021-03-17
Option Award
2021-03-19
4:55 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXCheruvu Pavan
Chief Executive Officer
22,590$080,426
(Direct)
View
2021-03-17
Disposition
2021-03-19
4:55 pm
N/A
N/A
Sio Gene Therapies Inc.SIOXCheruvu Pavan
Chief Executive Officer
22,590$080,426
(Direct)
View
2020-10-05
Option Award
2020-10-07
9:28 pm
N/A
2030-10-04
Axovant Gene Therapies Ltd.AXGTVuori Kristiina MD
Director
35,000$035,000
(Direct)
View
2020-06-11
Option Award
2020-06-15
7:40 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTNassif David W.
Principal Financial Officer
15,060$034,004
(Direct)
View
2020-06-11
Tax Withholding
2020-06-15
7:40 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTNassif David W.
Principal Financial Officer
5,266$3.2534,004
(Direct)
View
2020-06-12
Disposition
2020-06-15
7:40 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTNassif David W.
Principal Financial Officer
15,060$034,004
(Direct)
View
2020-06-11
Option Award
2020-06-15
7:39 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTCheruvu Pavan
Principal Executive Officer
22,591$042,926
(Direct)
View
2020-06-11
Disposition
2020-06-15
7:39 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTCheruvu Pavan
Principal Executive Officer
22,591$042,926
(Direct)
View
2020-06-11
Tax Withholding
2020-06-15
7:39 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTCheruvu Pavan
Principal Executive Officer
9,755$3.0942,926
(Direct)
View
2020-06-12
Option Award
2020-06-15
7:38 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTCorcoran Gavin
Chief R&D Officer
16,002$025,792
(Direct)
View
2020-06-12
Tax Withholding
2020-06-15
7:38 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTCorcoran Gavin
Chief R&D Officer
6,211$3.4625,792
(Direct)
View
2020-06-12
Disposition
2020-06-15
7:38 pm
N/A
N/A
Axovant Gene Therapies Ltd.AXGTCorcoran Gavin
Chief R&D Officer
16,002$025,792
(Direct)
View
2020-04-15
Option Award
2020-04-17
9:10 pm
N/A
2030-04-14
Axovant Gene Therapies Ltd.AXGTModig Berndt
Director
17,500$017,500
(Direct)
View
2020-04-15
Option Award
2020-04-17
9:09 pm
N/A
2030-04-14
Axovant Gene Therapies Ltd.AXGTPande Atul
Director
17,500$017,500
(Direct)
View
2020-04-15
Option Award
2020-04-17
9:07 pm
N/A
2030-04-14
Axovant Gene Therapies Ltd.AXGTTorti Frank
Director
17,500$017,500
(Direct)
View
2020-04-15
Option Award
2020-04-17
9:06 pm
N/A
2030-04-14
Axovant Gene Therapies Ltd.AXGTSundaram Senthil Vel
Director
17,500$017,500
(Direct)
View
2020-04-15
Option Award
2020-04-17
9:04 pm
N/A
2030-04-14
Axovant Gene Therapies Ltd.AXGTCorcoran Gavin
EVP of R&D
106,100$0106,100
(Direct)
View
2020-04-15
Option Award
2020-04-17
9:01 pm
N/A
2030-04-14
Axovant Gene Therapies Ltd.AXGTNassif David W.
Principal Financial Officer
131,500$0131,500
(Direct)
View
2020-04-15
Option Award
2020-04-17
8:59 pm
N/A
2030-04-14
Axovant Gene Therapies Ltd.AXGTCheruvu Pavan
Principal Executive Officer
281,800$0281,800
(Direct)
View